3D Systems Corp
DDD2.470USD
+0.230+10.27%
종가 09/18, 16:00（ET）시세는 15분 지연됩니다
316.13M시가총액
손실P/E TTM
자세한 내용은 3D Systems Corp 회사
3D Systems Corporation is an additive manufacturing solutions company. The Company provides three dimensional (3D) printing and digital manufacturing solutions, including 3D printers for plastics and metals, materials, software, and services, including maintenance, advanced manufacturing and applications engineering. Its segments include Healthcare Solutions and Industrial Solutions. Healthcare Solutions segment includes various industry verticals, such as dental, medical devices, personalized health services and regenerative medicine. Industrial Solutions segment includes various industry verticals, such as aerospace, defense, transportation and general manufacturing. It architects solutions specific to customers' needs through a combination of materials, hardware platforms, software, professional services and advanced manufacturing. It markets its products and services through subsidiaries in North America and South America, Europe and the Middle East and Asia Pacific and Oceania.
회사 정보
종목 코드 DDD
회사 이름3D Systems Corp
상장일Mar 26, 2011
CEODr. Jeffrey A. (Jeff) Graves, Ph.D.
직원 수1833
유형Ordinary Share
회계 연도 종료Mar 26
주소333 Three D Systems Cir
도시ROCK HILL
증권 거래소NYSE Consolidated
국가United States of America
우편 번호29730
전화18033263900
웹사이트https://www.3dsystems.com/
종목 코드 DDD
상장일Mar 26, 2011
CEODr. Jeffrey A. (Jeff) Graves, Ph.D.
회사 임원
이름
이름/직위
직위
주식 보유
변동
Dr. Charles W. Hull
Dr. Charles W. Hull
Executive Vice President, Chief Technology Officer - Regenerative Medicine
Executive Vice President, Chief Technology Officer - Regenerative Medicine
593.05K
-0.82%
Mr. Reji Puthenveetil
Mr. Reji Puthenveetil
Executive Vice President - Additive Solutions, Chief Commercial Officer
Executive Vice President - Additive Solutions, Chief Commercial Officer
431.53K
-3.59%
Mr. Kevin S. Moore
Mr. Kevin S. Moore
Independent Director
Independent Director
271.70K
+11.98%
Dr. John J. Tracy
Dr. John J. Tracy
Independent Director
Independent Director
180.71K
+19.17%
Dr. Vasant Padmanabhan
Dr. Vasant Padmanabhan
Independent Director
Independent Director
147.18K
+24.61%
Ms. Malissia R. Clinton
Ms. Malissia R. Clinton
Independent Director
Independent Director
--
--
Mr. Charles G. (Chip) Mcclure, Jr.
Mr. Charles G. (Chip) Mcclure, Jr.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Joseph (Joe) Zuiker
Mr. Joseph (Joe) Zuiker
Executive Vice President - Engineering and Operations
Executive Vice President - Engineering and Operations
--
--
Mr. Jimmy D. (Jim) Kever, J.D.
Mr. Jimmy D. (Jim) Kever, J.D.
Independent Director
Independent Director
--
--
Ms. Phyllis Nordstrom
Ms. Phyllis Nordstrom
Interim Chief Financial Officer, Principal Accounting Officer
Interim Chief Financial Officer, Principal Accounting Officer
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Dr. Charles W. Hull
Dr. Charles W. Hull
Executive Vice President, Chief Technology Officer - Regenerative Medicine
Executive Vice President, Chief Technology Officer - Regenerative Medicine
593.05K
-0.82%
Mr. Reji Puthenveetil
Mr. Reji Puthenveetil
Executive Vice President - Additive Solutions, Chief Commercial Officer
Executive Vice President - Additive Solutions, Chief Commercial Officer
431.53K
-3.59%
Mr. Kevin S. Moore
Mr. Kevin S. Moore
Independent Director
Independent Director
271.70K
+11.98%
Dr. John J. Tracy
Dr. John J. Tracy
Independent Director
Independent Director
180.71K
+19.17%
Dr. Vasant Padmanabhan
Dr. Vasant Padmanabhan
Independent Director
Independent Director
147.18K
+24.61%
Ms. Malissia R. Clinton
Ms. Malissia R. Clinton
Independent Director
Independent Director
--
--
수익 분석
통화: USD마지막 업데이트: Sun, Jul 6
통화: USD마지막 업데이트: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
사업별USD
이름
수익
비율
Products
54.72M
57.88%
Services
39.82M
42.12%
데이터 없음
사업별
지역별
사업별USD
이름
수익
비율
Products
54.72M
57.88%
Services
39.82M
42.12%
주식 보유 통계
마지막 업데이트: Sun, Aug 17
마지막 업데이트: Sun, Aug 17
주주
주주 유형
주주
주주
비율
State Street Global Advisors (US)
7.71%
BlackRock Institutional Trust Company, N.A.
7.20%
The Vanguard Group, Inc.
5.77%
Geode Capital Management, L.L.C.
2.47%
Millennium Management LLC
2.46%
기타
74.39%
주주
주주
비율
State Street Global Advisors (US)
7.71%
BlackRock Institutional Trust Company, N.A.
7.20%
The Vanguard Group, Inc.
5.77%
Geode Capital Management, L.L.C.
2.47%
Millennium Management LLC
2.46%
기타
74.39%
주주 유형
주주
비율
Investment Advisor
23.49%
Investment Advisor/Hedge Fund
17.11%
Hedge Fund
6.38%
Individual Investor
4.28%
Research Firm
3.93%
Family Office
1.11%
Bank and Trust
0.17%
Venture Capital
0.15%
Pension Fund
0.08%
기타
43.29%
기관 주식 보유
마지막 업데이트: Tue, Jul 1
마지막 업데이트: Tue, Jul 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q2
570
68.79M
50.43%
-21.87M
2025Q1
587
72.49M
53.18%
-18.98M
2024Q4
592
79.50M
58.62%
-5.75M
2024Q3
589
77.38M
57.87%
-20.75M
2024Q2
584
90.33M
67.61%
-8.75M
2024Q1
591
91.23M
68.27%
-11.77M
2023Q4
599
91.77M
68.70%
-8.99M
2023Q3
605
90.63M
67.88%
-16.10M
2023Q2
615
94.67M
72.15%
-10.52M
2023Q1
640
92.61M
71.04%
-9.20M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
State Street Global Advisors (US)
5.97M
4.37%
+2.04K
+0.03%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
9.01M
6.6%
+93.54K
+1.05%
Mar 31, 2025
The Vanguard Group, Inc.
7.30M
5.35%
+193.56K
+2.72%
Mar 31, 2025
Geode Capital Management, L.L.C.
3.06M
2.24%
+74.90K
+2.51%
Mar 31, 2025
Millennium Management LLC
1.62M
1.19%
-1.97M
-54.82%
Mar 31, 2025
Two Sigma Investments, LP
2.70M
1.98%
-226.90K
-7.75%
Mar 31, 2025
ICON Advisers, Inc.
2.10M
1.54%
+500.00K
+31.25%
Mar 31, 2025
Silverberg Bernstein Capital Management, LLC
1.53M
1.12%
+210.81K
+15.93%
Mar 31, 2025
Morgan Stanley & Co. LLC
992.58K
0.73%
-95.32K
-8.76%
Mar 31, 2025
더 보기
관련 ETF
이름
비율
데이터 없음
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음
